-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CzX7wwCiBI3V0OfG64uwc1kWT3zlH1Vp1b5f9Dvn+sqwe/vUml3QxFTBNjEkplDj i/Ke8h3y1LW/nuY5jlMISg== 0000810084-09-000001.txt : 20090102 0000810084-09-000001.hdr.sgml : 20090101 20090102190123 ACCESSION NUMBER: 0000810084-09-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081231 FILED AS OF DATE: 20090102 DATE AS OF CHANGE: 20090102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Makar Ralph CENTRAL INDEX KEY: 0001414579 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15360 FILM NUMBER: 09502255 BUSINESS ADDRESS: BUSINESS PHONE: 503-691-4132 MAIL ADDRESS: STREET 1: 20245 SW 95TH AVENUE CITY: TUALATIN STATE: OR ZIP: 97062 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOJECT MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000810084 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 931099680 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20245 SW 95TH AVENUE CITY: TUALATIN STATE: OR ZIP: 97062 BUSINESS PHONE: 5036928001 MAIL ADDRESS: STREET 1: 20245 SW 95TH AVENUE CITY: TUALATIN STATE: OR ZIP: 97062 FORMER COMPANY: FORMER CONFORMED NAME: BIOJECT MEDICAL SYSTEMS LTD DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2008-12-31 0 0000810084 BIOJECT MEDICAL TECHNOLOGIES INC BJCT 0001414579 Makar Ralph 20245 SW 95TH AVENUE TUALATIN OR 97062 0 1 0 0 CEO/President BJCT Common Stock 2008-12-31 4 M 0 50000 0 A 295701 D BJCT Common Stock 15441 I 401K Restricted Stock Unit 2008-12-31 4 M 0 50000 0 D 2008-12-31 BJCT Common Stock 50000 390934 D 1/3 vesting per Executive Employment Agreement date October 1, 2007. Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock. No expiration date. Includes Series F Preferred Stock 67,600, Warrant (right-to-buy) 6,667, Option (right-to-buy) 150,000 Restricted Stock Unit 166,667. //Christine M. Farrell Attorney-in-Fact for Ralph Makar// 2009-01-02 -----END PRIVACY-ENHANCED MESSAGE-----